The goal of this workshop is to bring together experts from nanomedicine, AI, clinical research, and regulation to co-develop smarter, safer, and more effective drug delivery systems.
This workshop focuses on advancing how we design and evaluate drug delivery systems using data-driven methods. Despite their potential, most nanomedicines fail to reach patients due to high costs, slow development, and limited reliability. By connecting scientists, clinicians, industry, and regulators, the workshop will explore how to make these systems more transparent, trustworthy, and clinically relevant. Through talks, team-based sessions, and hands-on activities, participants will identify key challenges, share strategies, and draft a roadmap for future collaboration, aiming to improve treatments for complex diseases like cancer.